Identifying the correlation between drug/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology.

Wet media milling by top down method has proved to be an effective method to prepare nanosuspension of poorly soluble drugs/APIs. Few or no attempts have been made so far to understand the feasibility of nanosuspension formulation in terms of the mechanism of stabilization as a function of drug properties. The objective of this study was to understand the effect of drug substance and stabilizer properties to form a successful nanosuspension product. From this study, logP and enthalpy were concluded to have a direct correlation on the feasibility of formation of a stable nanosuspension. The most likely candidate for media milling was a drug substance with a high enthalpy and hydrophobicity which can be stabilized either electrostatically or sterically. The least likely candidate will be one that is hydrophilic and having a very low enthalpy value. Also the choice of an ideal stabilizer/surfactant was found to be influenced by the degree of hydrophobicity of the drug itself. Finally the morphology of the starting drug was found to significantly affect the milling time required to produce submicron particles.

[1]  Michael Juhnke,et al.  Accelerated Formulation Development for Nanomilled Active Pharmaceutical Ingredients Using a Screening Approach , 2010 .

[2]  Marie-Isabelle Baraton,et al.  Synthesis, Functionalization and Surface Treatment of Nanoparticles , 2002 .

[3]  P. W. Carter,et al.  Anion effects on electrostatic charging of sterically stabilized, water insoluble drug particles. , 2009, International journal of pharmaceutics.

[4]  Yasuo Ida,et al.  Solubilization behavior of a poorly soluble drug under combined use of surfactants and cosolvents. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[5]  Koichi Wada,et al.  Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. , 2011, International journal of pharmaceutics.

[6]  M. Mazzotti,et al.  Miconazole nanosuspensions: Influence of formulation variables on particle size reduction and physical stability. , 2010, International journal of pharmaceutics.

[7]  Huibi Xu,et al.  Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility. , 2011, International journal of pharmaceutics.

[8]  Patrick Augustijns,et al.  Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. , 2008, International journal of pharmaceutics.

[9]  Elaine Merisko-Liversidge,et al.  Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology. , 2011, Advanced drug delivery reviews.

[10]  I. Ghosh,et al.  Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth. , 2011, International journal of pharmaceutics.

[11]  J-Y Choi,et al.  Characteristics of polymers enabling nano-comminution of water-insoluble drugs. , 2008, International journal of pharmaceutics.

[12]  M. K. Lee,et al.  Hydrophilic and hydrophobic amino acid copolymers for nano-comminution of poorly soluble drugs. , 2010, International journal of pharmaceutics.

[13]  Toshiyuki Niwa,et al.  Universal wet-milling technique to prepare oral nanosuspension focused on discovery and preclinical animal studies - Development of particle design method. , 2011, International journal of pharmaceutics.

[14]  R. Müller,et al.  Nanosuspensions of poorly soluble drugs--reproducibility of small scale production. , 2000, International journal of pharmaceutics.

[15]  P Amsa,et al.  Nanosuspensions: A Promising Drug Delivery Strategy , 2010 .

[16]  Brahmeshwar Mishra,et al.  Lipid--an emerging platform for oral delivery of drugs with poor bioavailability. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[17]  D. Burgess,et al.  Scanning probe microscopy method for nanosuspension stabilizer selection. , 2009, Langmuir : the ACS journal of surfaces and colloids.

[18]  E. Merisko-Liversidge,et al.  Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds , 2008, Toxicologic pathology.

[19]  Timo Laaksonen,et al.  Nanosuspensions of poorly soluble drugs: preparation and development by wet milling. , 2011, International journal of pharmaceutics.

[20]  Jonghwi Lee,et al.  Role of polymeric stabilizers for drug nanocrystal dispersions , 2005 .

[21]  S. Garg,et al.  Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs. , 2010, Advanced drug delivery reviews.

[22]  Ludo Froyen,et al.  A screening study of surface stabilization during the production of drug nanocrystals. , 2009, Journal of pharmaceutical sciences.

[23]  A Philip Plumb,et al.  A decision-support tool for the formulation of orally active, poorly soluble compounds. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[24]  I. Ghosh,et al.  Optimization of formulation and process parameters for the production of nanosuspension by wet media milling technique: effect of Vitamin E TPGS and nanocrystal particle size on oral absorption. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[25]  Rainer H Müller,et al.  Nanocrystal technology, drug delivery and clinical applications , 2008, International journal of nanomedicine.

[26]  K. Amighi,et al.  Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[27]  S Kumar,et al.  Physical stability of nanosuspensions: investigation of the role of stabilizers on Ostwald ripening. , 2011, International journal of pharmaceutics.

[28]  R. Müller,et al.  Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. , 2001, Advanced drug delivery reviews.

[29]  Diane J Burgess,et al.  Quality by design approach to understand the process of nanosuspension preparation. , 2009, International journal of pharmaceutics.

[30]  K. Matsuzaki,et al.  Solubility enhancement of hydrophobic compounds by cosolvents: role of solute hydrophobicity on the solubilization effect. , 2010, International journal of pharmaceutics.

[31]  Sanjay Garg,et al.  Evaluation of a crystalline nanosuspension: polymorphism, process induced transformation and in vivo studies. , 2011, International journal of pharmaceutics.

[32]  S. Stegemann,et al.  When poor solubility becomes an issue: from early stage to proof of concept. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[33]  Rainer H Müller,et al.  Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[34]  Jian Zhang,et al.  Physical and chemical stability of drug nanoparticles. , 2011, Advanced drug delivery reviews.

[35]  Filippos Kesisoglou,et al.  Nanosizing--oral formulation development and biopharmaceutical evaluation. , 2007, Advanced drug delivery reviews.

[36]  Jouni Hirvonen,et al.  Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods , 2010, The Journal of pharmacy and pharmacology.

[37]  C. Lipinski Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.

[38]  K. Amighi,et al.  Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. , 2005, International journal of pharmaceutics.

[39]  Michael Lee Branham,et al.  Preparation and solid-state characterization of ball milled saquinavir mesylate for solubility enhancement. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.